Shares in Axsome Therapeutics have rocketed on FDA approval ... to Johnson & Johnson's Spravato (esketamine), which was approved in March 2019 and is administered as a nasal spray twice a week ...

If you've been HBO’s new season of White Lotus, then you've seen Parker Posey’s character Victoria Ratliff popping a steady ...

Johnson & Johnson has priced its new ... 25% and 52% cheaper to meet its value threshold. The spray – which was approved by the FDA in March – has a wholesale acquisition cost of $295 per ...

A month into his role as health and human services secretary, Robert F. Kennedy Jr.'s moves on vaccines have worried health ...

Johnson & Johnson MedTech announced today that the FDA cleared its Monarch Quest technology for robotic-assisted bronchoscopy ...

Milestone Pharmaceuticals Inc. announced that the FDA has ... for its nasal spray CARDAMYST™ (etripamil), aimed at treating Paroxysmal Supraventricular Tachycardia (PSVT). If approved, Milestone ...

Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...

Johnson & Johnson's nipocalimab earns FDA Fast Track status for Sjögren's disease, speeding development and review for unmet medical needs.

The US Food and Drug Administration (FDA) has approved the ... chronic rhinosinusitis with nasal polyps, chronic unexplained hives, and food allergies. The approval “will help broaden access ...

Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...

Speaker Mike Johnson (R-La.) is weighing his options after a bipartisan group led by Rep. Anna Paulina Luna (R-Fla.) garnered enough support to force a floor vote on legislation to allow proxy vot ...